A novel GSK3β inhibitor 5n attenuates acute kidney injury
Open Access
Abstract
No abstract availableKeywords
Funding Information
- Anhui Medical University (2019xkj057)
- Anhui Medical University (2023AH050674)
This publication has 62 references indexed in Scilit:
- Mechanism of PP2A-mediated IKKβ dephosphorylation: a systems biological approachBMC Systems Biology, 2009
- Activation of glycogen synthase kinase-3 inhibits protein phosphatase-2A and the underlying mechanismsNeurobiology of Aging, 2008
- Phosphorylated GSK3beta-ser9 and EGFR are good prognostic factors for lung carcinomas.2007
- RNAi Screen in Mouse Astrocytes Identifies Phosphatases that Regulate NF-κB SignalingMolecular Cell, 2006
- Glycogen Synthase Kinase-3 (GSK3): Inflammation, Diseases, and TherapeuticsNeurochemical Research, 2006
- GSK-3β inhibitors attenuate the organ injury/dysfunction caused by endotoxemia in the rat*Critical Care Medicine, 2005
- Pharmacological inhibitors of glycogen synthase kinase 3Trends in Pharmacological Sciences, 2004
- GSK3 inhibitors: development and therapeutic potentialNature Reviews Drug Discovery, 2004
- Inhibition of glycogen synthase kinase-3 by insulin mediated by protein kinase BNature, 1995
- Activation of protein kinases and the inactivation of protein phosphatase 2A in tumour necrosis factor and interleukin-1 signal-transduction pathways.1995